Bettina Lorenz-Depiereux Selected Research

Endopeptidases

1/2018

The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bettina Lorenz-Depiereux Research Topics

Disease

5	Hypophosphatemia 01/2018 - 02/2006
3	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2018 - 08/2004
3	Hypophosphatemic Rickets 07/2015 - 02/2005
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Calcinosis 07/2006 - 02/2005
2	Rickets (Rachitis) 02/2006 - 08/2004
2	Autosomal Dominant Hypophosphatemic Rickets 02/2006 - 08/2004
1	Infections 12/2023
1	Severe Acute Respiratory Syndrome 07/2023
1	Familial Hyperphosphatemic Tumoral Calcinosis 02/2021
1	Paralysis (Palsy) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Chronic Renal Insufficiency 01/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Arterial calcification of infancy 07/2015
1	Hypertension (High Blood Pressure) 07/2015
1	Hearing Loss (Hearing Impairment) 07/2015
1	Pulmonary Alveolar Proteinosis 05/2015
1	Pain (Aches) 11/2014
1	Autoimmune Diseases (Autoimmune Disease) 08/2013
1	Metabolic Bone Diseases (Osteopenia) 08/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2010
1	Congenital Hyperinsulinism 03/2008
1	Intellectual Disability (Idiocy) 10/2007
1	Uniparental Disomy 10/2007
1	Familial Hypophosphatemia (Phosphate Diabetes) 11/2006
1	Hereditary Hypophosphatemic Rickets with Hypercalciuria 02/2006
1	Hypercalciuria 02/2006
1	Epilepsy (Aura) 07/2005
1	Migraine with Aura (Familial Hemiplegic Migraine) 07/2005
1	Osteomalacia 08/2004
1	Myoclonic dystonia 02/2003

Drug/Important Bio-Agent (IBA)

8	Phosphates (Orthophosphate)IBA 01/2018 - 08/2004
4	Fibroblast Growth Factor-23IBA 02/2021 - 02/2006
3	Proteins (Proteins, Gene)FDA Link 02/2010 - 02/2006
2	CalcineurinIBA 01/2021 - 01/2018
2	Vitamin D FDA LinkGeneric 01/2018 - 11/2014
2	1,25-dihydroxyvitamin DIBA 02/2010 - 02/2006
1	SteroidsIBA 12/2023
1	MineralsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Amine Oxidase (Copper-Containing)IBA 01/2020
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	EndopeptidasesIBA 01/2018
1	nucleotide pyrophosphataseIBA 07/2015
1	Methionine-tRNA LigaseIBA 05/2015
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 08/2013
1	Alkaline PhosphataseIBA 08/2013
1	CollagenIBA 08/2013
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2010
1	PyrophosphatasesIBA 02/2010
1	Levodopa (L Dopa)FDA LinkGeneric 03/2008
1	OligonucleotidesIBA 10/2007
1	hydroxide ionIBA 11/2006
1	Polypeptide N-acetylgalactosaminyltransferaseIBA 07/2006
1	GlycosyltransferasesIBA 07/2006
1	Peptides (Polypeptides)IBA 07/2006
1	Sodium-Phosphate Cotransporter Proteins (Sodium-Phosphate Cotransporter)IBA 02/2006
1	Sodium Channels (Sodium Channel)IBA 07/2005
1	Voltage-Gated Sodium ChannelsIBA 07/2005
1	RacivirIBA 02/2005
1	Sarcoglycans (beta Sarcoglycan)IBA 02/2003

Therapy/Procedure

2	Therapeutics 07/2023 - 01/2020
1	Hearing Aids (Hearing Aid) 07/2015